THE EFFECT OF CHRONIC PHENYTOIN-TREATMENT ON SERUM-LIPID PROFILE IN ADULT EPILEPTIC PATIENTS

被引:28
作者
CALANDRE, EP
PORTA, BS
DELACALZADA, DG
机构
[1] UNIV HOSP GRANADA, DEPT CLIN PHARMACOL, GRANADA, SPAIN
[2] SCH MED MED ZARAGOZA, DEPT CLIN PHARMACOL, ZARAGOZA, SPAIN
关键词
EPILEPSY; ANTICONVULSANTS; PHENYTOIN; DRUG-INDUCED ABNORMALITIES; CHOLESTEROL; LIPOPROTEINS; APOLIPOPROTEINS;
D O I
10.1111/j.1528-1157.1992.tb02299.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very-low-density lipoprotein cholesterol, apolipoproteins A, A1, and B and gamma-glutamyltransferase (ggt) serum concentrations were measured in 100 adult epileptic patients receiving chronic phenytoin (PHT) treatment and in 100 control subjects. In relation to controls, patients showed higher HDL cholesterol, apolipoproteins A and A1, and ggt levels and lower LDL cholesterol and apolipoprotein B values; the significance of the results was greater in women than in men. Among patients, ggt levels were positively correlated with PHT plasma concentrations; likewise, a negative correlation was found between the apolipoprotein A/A1 ratio and the PHT and ggt plasma levels, and a positive correlation between the apolipoprotein A/A1 ratio and the LDL/HDL cholesterol ratio. These data indicate that PHT exerts a beneficial effect on the serum lipids profile.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 14 条
[1]  
BERLIT P, 1982, ACTA NEUROL SCAND, V66, P328
[2]   SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B IN EPILEPTIC PATIENTS TREATED WITH VALPROIC ACID, CARBAMAZEPINE OR PHENOBARBITAL [J].
CALANDRE, EP ;
RODRIGUEZLOPEZ, C ;
BLAZQUEZ, A ;
CANO, D .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (04) :250-253
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]   THE EFFECT OF CHRONIC ANTI-CONVULSANT THERAPY ON SERUM-LIPIDS AND LIPOPROTEINS IN EPILEPTIC CHILDREN [J].
HELDENBERG, D ;
HAREL, S ;
HOLTZMAN, M ;
LEVTOW, O ;
TAMIR, I .
NEUROLOGY, 1983, 33 (04) :510-513
[6]   ELECTROIMMUNO ASSAY [J].
LAURELL, CB .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 :21-&
[7]   RELATIONSHIP BETWEEN PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ANTICONVULSANT LEVELS IN EPILEPTICS [J].
LUOMA, PV ;
MYLLYLA, VV ;
HOKKANEN, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :1024-1027
[8]   SERUM LOW-DENSITY LIPOPROTEIN AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, AND LIVER SIZE IN SUBJECTS ON DRUGS INDUCING HEPATIC-MICROSOMAL ENZYMES [J].
LUOMA, PV ;
SOTANIEMI, EA ;
PELKONEN, RO ;
PIRTTIAHO, HI .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) :615-618
[9]   PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND HEPATIC CYTOCHROME-P-450 CONCENTRATIONS IN EPILEPTICS UNDERGOING ANTICONVULSANT TREATMENT [J].
LUOMA, PV ;
SOTANIEMI, EA ;
PELKONEN, RO ;
MYLLYLA, VV .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1980, 40 (02) :163-167
[10]  
NIKKILA EA, 1978, ACTA MED SCAND, V204, P517